|
The stock could double on approval, but, after the recent gains I'm predicting a more conservative estimate of an initial spike to around ten dollars, followed by a retracement on profit taking to eight before eventually settling at twelve. From that point, Onsolis sales and the progress made in international approvals will dictate the price of the stock.
In order to raise additional cash, it is possible that the company will choose to conduct a stock offering after the approval announcement, should the FDA decide to approve. That will decrease the value of existing shares, but once approval is in the bag, revenue will not be too far off and the stock price will rebound.
__________________
Bonus facilities by AVAFX only had to send a code AVAQZ12 and deposit of $200 to get $100 more.
|